annual SGA:
$0.00-$429.68M(-100.00%)Summary
- As of today (September 18, 2025), AMRX annual SGA is $0.00, with the most recent change of -$429.68 million (-100.00%) on December 31, 2024.
- During the last 3 years, AMRX annual SGA has fallen by -$365.50 million (-100.00%).
- AMRX annual SGA is now -100.00% below its all-time high of $429.68 million, reached on December 31, 2023.
Performance
AMRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$0.00-$118.29M(-100.00%)Summary
- As of today (September 18, 2025), AMRX quarterly SGA is $0.00, with the most recent change of -$118.29 million (-100.00%) on June 30, 2025.
- Over the past year, AMRX quarterly SGA has dropped by -$116.46 million (-100.00%).
- AMRX quarterly SGA is now -100.00% below its all-time high of $118.69 million, reached on September 30, 2024.
Performance
AMRX quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$2.35B+$3.38M(+0.14%)Summary
- As of today (September 18, 2025), AMRX TTM SGA is -$2.35 billion, with the most recent change of +$3.38 million (+0.14%) on June 30, 2025.
- Over the past year, AMRX TTM SGA has dropped by -$2.80 billion (-621.07%).
- AMRX TTM SGA is now -204.65% below its all-time high of $2.25 billion.
Performance
AMRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AMRX Selling, general & administrative expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -100.0% | -100.0% | -621.1% |
3 y3 years | -100.0% | -100.0% | -708.8% |
5 y5 years | -100.0% | -100.0% | -891.9% |
AMRX Selling, general & administrative expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -100.0% | at low | -100.0% | at low | -92.1% | +0.1% |
5 y | 5-year | -100.0% | at low | -100.0% | at low | -115.6% | +0.1% |
alltime | all time | -100.0% | at low | -100.0% | at low | -204.7% | +0.1% |
AMRX Selling, general & administrative expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $0.00(-100.0%) | $236.98M(-33.0%) |
Mar 2025 | - | $118.29M(>+9900.0%) | $353.44M(+1.6%) |
Dec 2024 | $0.00(-100.0%) | $0.00(-100.0%) | $347.75M(-23.9%) |
Sep 2024 | - | $118.69M(+1.9%) | $456.75M(+1.3%) |
Jun 2024 | - | $116.46M(+3.4%) | $451.07M(+2.5%) |
Mar 2024 | - | $112.59M(+3.3%) | $440.17M(+2.4%) |
Dec 2023 | $429.68M(+7.5%) | $109.00M(-3.5%) | $429.68M(+1.6%) |
Sep 2023 | - | $113.01M(+7.0%) | $422.83M(+3.2%) |
Jun 2023 | - | $105.57M(+3.4%) | $409.89M(+1.7%) |
Mar 2023 | - | $102.10M(-0.1%) | $403.13M(+0.9%) |
Dec 2022 | $399.70M(+9.4%) | $102.16M(+2.1%) | $399.70M(+1.2%) |
Sep 2022 | - | $100.07M(+1.3%) | $394.77M(+2.2%) |
Jun 2022 | - | $98.81M(+0.1%) | $386.09M(+3.4%) |
Mar 2022 | - | $98.67M(+1.5%) | $373.44M(+2.2%) |
Dec 2021 | $365.50M(+11.9%) | $97.22M(+6.4%) | $365.50M(+3.6%) |
Sep 2021 | - | $91.40M(+6.1%) | $352.97M(+2.4%) |
Jun 2021 | - | $86.16M(-5.0%) | $344.69M(+1.5%) |
Mar 2021 | - | $90.73M(+7.1%) | $339.48M(+3.9%) |
Dec 2020 | $326.73M(+12.8%) | $84.69M(+1.9%) | $326.73M(+3.4%) |
Sep 2020 | - | $83.12M(+2.7%) | $316.12M(+6.5%) |
Jun 2020 | - | $80.94M(+3.8%) | $296.80M(+4.8%) |
Mar 2020 | - | $77.98M(+5.3%) | $283.14M(-2.2%) |
Dec 2019 | $289.60M(+25.7%) | $74.08M(+16.1%) | $289.60M(-0.1%) |
Sep 2019 | - | $63.80M(-5.2%) | $289.75M(-4.7%) |
Jun 2019 | - | $67.28M(-20.3%) | $304.03M(+4.9%) |
Mar 2019 | - | $84.44M(+13.7%) | $289.75M(+25.7%) |
Dec 2018 | $230.44M(+111.3%) | $74.24M(-4.9%) | $230.44M(+25.8%) |
Sep 2018 | - | $78.08M(+47.3%) | $183.16M(+38.2%) |
Jun 2018 | - | $53.00M(+111.0%) | $132.53M(+24.5%) |
Mar 2018 | - | $25.12M(-6.8%) | $106.47M(+30.9%) |
Dec 2017 | $109.05M(-46.0%) | $26.97M(-1.7%) | $81.34M(-27.3%) |
Sep 2017 | - | $27.44M(+1.9%) | $111.96M(-19.8%) |
Jun 2017 | - | $26.94M(>+9900.0%) | $139.56M(-11.4%) |
Mar 2017 | - | $0.00(-100.0%) | $157.53M(-21.9%) |
Dec 2016 | $201.83M(+0.3%) | - | - |
Dec 2016 | - | $57.59M(+4.6%) | $201.83M(+0.5%) |
Sep 2016 | - | $55.04M(+22.6%) | $200.75M(+4.5%) |
Jun 2016 | - | $44.91M(+1.4%) | $192.02M(-1.7%) |
Mar 2016 | - | $44.30M(-21.6%) | $195.43M(-2.9%) |
Dec 2015 | $201.29M(+44.4%) | $56.51M(+22.0%) | $201.29M(+7.6%) |
Sep 2015 | - | $46.31M(-4.1%) | $186.98M(+4.1%) |
Jun 2015 | - | $48.31M(-3.7%) | $179.56M(+9.4%) |
Mar 2015 | - | $50.16M(+18.8%) | $164.07M(+17.7%) |
Dec 2014 | $139.39M(+15.9%) | $42.21M(+8.5%) | $139.39M(+10.2%) |
Sep 2014 | - | $38.89M(+18.5%) | $126.51M(+9.4%) |
Jun 2014 | - | $32.82M(+28.8%) | $115.59M(-0.4%) |
Mar 2014 | - | $25.48M(-13.1%) | $116.05M(-3.5%) |
Dec 2013 | $120.29M(+10.9%) | $29.33M(+4.9%) | $120.29M(-3.3%) |
Sep 2013 | - | $27.97M(-15.9%) | $124.40M(-0.8%) |
Jun 2013 | - | $33.27M(+12.0%) | $125.36M(+7.2%) |
Mar 2013 | - | $29.72M(-11.1%) | $116.95M(+7.8%) |
Dec 2012 | $108.47M | $33.44M(+15.6%) | $108.47M(+14.1%) |
Sep 2012 | - | $28.93M(+16.3%) | $95.10M(+15.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2012 | - | $24.87M(+17.1%) | $82.49M(+12.8%) |
Mar 2012 | - | $21.23M(+5.8%) | $73.13M(+6.8%) |
Dec 2011 | $68.48M(+28.4%) | $20.07M(+23.0%) | $68.48M(+6.0%) |
Sep 2011 | - | $16.32M(+5.2%) | $64.60M(+6.1%) |
Jun 2011 | - | $15.51M(-6.5%) | $60.91M(+7.2%) |
Mar 2011 | - | $16.58M(+2.4%) | $56.85M(+7.8%) |
Dec 2010 | $53.33M(+34.3%) | $16.19M(+28.2%) | $52.75M(+44.3%) |
Sep 2010 | - | $12.63M(+10.4%) | $36.56M(+8.3%) |
Jun 2010 | - | $11.44M(-8.3%) | $33.77M(+4.3%) |
Mar 2010 | - | $12.48M(>+9900.0%) | $32.36M(+3.3%) |
Dec 2009 | $39.71M(-17.1%) | $0.00(-100.0%) | $31.33M(-26.4%) |
Sep 2009 | - | $9.84M(-2.0%) | $42.56M(-10.1%) |
Jun 2009 | - | $10.04M(-12.4%) | $47.36M(-4.0%) |
Mar 2009 | - | $11.46M(+2.0%) | $49.34M(+2.3%) |
Dec 2008 | $47.90M(+21.0%) | $11.23M(-23.3%) | $48.25M(-0.9%) |
Sep 2008 | - | $14.64M(+21.8%) | $48.70M(+12.7%) |
Jun 2008 | - | $12.02M(+16.0%) | $43.22M(+6.7%) |
Mar 2008 | - | $10.36M(-11.2%) | $40.50M(+2.3%) |
Dec 2007 | $39.57M(+22.3%) | $11.68M(+27.5%) | $39.57M(+5.8%) |
Sep 2007 | - | $9.16M(-1.5%) | $37.39M(+6.8%) |
Jun 2007 | - | $9.30M(-1.4%) | $35.00M(+1.5%) |
Mar 2007 | - | $9.43M(-0.7%) | $34.49M(+6.6%) |
Dec 2006 | $32.36M(+25.6%) | $9.50M(+40.4%) | $32.36M(+41.5%) |
Sep 2006 | - | $6.77M(-23.0%) | $22.86M(+42.0%) |
Jun 2006 | - | $8.79M(+20.3%) | $16.10M(+120.3%) |
Mar 2006 | - | $7.31M(+74.1%) | $7.31M(-53.4%) |
Dec 2005 | $25.76M(+120.7%) | - | - |
Sep 2004 | - | $4.20M(+9.6%) | $15.70M(+9.3%) |
Jun 2004 | - | $3.83M(-6.1%) | $14.37M(+10.0%) |
Mar 2004 | - | $4.08M(+13.4%) | $13.06M(+11.9%) |
Dec 2003 | $11.67M(+3.9%) | $3.59M(+25.4%) | $11.67M(+44.5%) |
Sep 2003 | - | $2.87M(+13.7%) | $8.08M(+1.1%) |
Jun 2003 | - | $2.52M(-6.3%) | $7.99M(-0.8%) |
Mar 2003 | - | $2.69M(>+9900.0%) | $8.06M(-0.5%) |
Dec 2002 | $11.23M(+48.7%) | $0.00(-100.0%) | $8.10M(0.0%) |
Sep 2002 | - | $2.78M(+7.6%) | $8.10M(+12.3%) |
Jun 2002 | - | $2.58M(-5.4%) | $7.21M(+7.7%) |
Mar 2002 | - | $2.73M(>+9900.0%) | $6.69M(+22.5%) |
Dec 2001 | $7.56M(+16.1%) | $0.00(-100.0%) | $5.47M(0.0%) |
Sep 2001 | - | $1.89M(-8.6%) | $5.47M(+52.9%) |
Jun 2001 | - | $2.07M(+37.6%) | $3.57M(+137.6%) |
Mar 2001 | - | $1.50M(>+9900.0%) | $1.50M(>+9900.0%) |
Dec 2000 | $6.51M(>+9900.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 1999 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 1998 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
Sep 1998 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 1998 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 1998 | - | $0.00 | $0.00 |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual SGA?
- What is the all time high annual SGA for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual SGA year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly SGA?
- What is the all time high quarterly SGA for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly SGA year-on-year change?
- What is Amneal Pharmaceuticals, Inc. TTM SGA?
- What is the all time high TTM SGA for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. TTM SGA year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual SGA?
The current annual SGA of AMRX is $0.00
What is the all time high annual SGA for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual SGA is $429.68M
What is Amneal Pharmaceuticals, Inc. annual SGA year-on-year change?
Over the past year, AMRX annual SGA has changed by -$429.68M (-100.00%)
What is Amneal Pharmaceuticals, Inc. quarterly SGA?
The current quarterly SGA of AMRX is $0.00
What is the all time high quarterly SGA for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly SGA is $118.69M
What is Amneal Pharmaceuticals, Inc. quarterly SGA year-on-year change?
Over the past year, AMRX quarterly SGA has changed by -$116.46M (-100.00%)
What is Amneal Pharmaceuticals, Inc. TTM SGA?
The current TTM SGA of AMRX is -$2.35B
What is the all time high TTM SGA for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high TTM SGA is $2.25B
What is Amneal Pharmaceuticals, Inc. TTM SGA year-on-year change?
Over the past year, AMRX TTM SGA has changed by -$2.80B (-621.07%)